Company intelligence / Profile preview
Sonoma Pharmaceuticals, Inc.
Boulder, Colorado, United Statessonomapharma.com ↗
- Ownership
- Public · SNOA
- Employees
- ~172
- Development stage
- Commercial
01
Overview
Sonoma Pharmaceuticals develops and produces stabilized hypochlorous acid (HOCl) products for various applications including wound care, dermatology, animal health care, and non-toxic disinfectants. Their products are clinically proven to reduce itch, pain, scarring, and irritation safely without damaging healthy tissue.
- Therapeutic areas
- OtherOphthalmologyDermatology
- Modalities
- Hypochlorous acid (HOCl) based products
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
MicroSafe
04
Financials
- Market cap
- $5.1M
- Total revenue
- $19.5M
- Enterprise value
- $524.6K
Beyond the preview
Go deeper on Sonoma Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sonoma Pharmaceuticals, Inc..